Published in J Thorac Cardiovasc Surg on October 26, 2005
CD133+ Cell Therapy for Refractory Coronary Heart Disease | NCT01049867
Cell therapy for heart failure: a comprehensive overview of experimental and clinical studies, current challenges, and future directions. Circ Res (2013) 3.56
Marrow stromal cells differentiate into vasculature after allogeneic transplantation into ischemic myocardium. Ann Thorac Surg (2011) 1.59
Mechanisms of bone marrow-derived cell therapy in ischemic cardiomyopathy with left ventricular assist device bridge to transplant. J Am Coll Cardiol (2015) 1.45
Direct injection of autologous mesenchymal stromal cells improves myocardial function. Biochem Biophys Res Commun (2009) 1.08
Transplantation of human menstrual blood stem cells to treat premature ovarian failure in mouse model. Stem Cells Dev (2014) 1.04
Plasticity of human menstrual blood stem cells derived from the endometrium. J Zhejiang Univ Sci B (2011) 1.01
Endometrial regenerative cells for treatment of heart failure: a new stem cell enters the clinic. J Transl Med (2013) 0.96
Cell delivery and tracking in post-myocardial infarction cardiac stem cell therapy: an introduction for clinical researchers. Heart Fail Rev (2010) 0.93
Programming and reprogramming a human heart cell. EMBO J (2015) 0.92
Intravitreal autologous bone marrow CD34+ cell therapy for ischemic and degenerative retinal disorders: preliminary phase 1 clinical trial findings. Invest Ophthalmol Vis Sci (2014) 0.89
Current stem cell delivery methods for myocardial repair. Biomed Res Int (2012) 0.89
Bone Marrow Stem Cell Treatment for Ischemic Heart Disease in Patients with No Option of Revascularization: A Systematic Review and Meta-Analysis. PLoS One (2013) 0.87
Stem cell therapy and breast cancer treatment: review of stem cell research and potential therapeutic impact against cardiotoxicities due to breast cancer treatment. Front Oncol (2014) 0.85
Regulatory T cells enhance mesenchymal stem cell survival and proliferation following autologous cotransplantation in ischemic myocardium. J Thorac Cardiovasc Surg (2014) 0.84
Small intestinal submucosa gel as a potential scaffolding material for cardiac tissue engineering. Acta Biomater (2009) 0.84
Heterogeneity in SDF-1 expression defines the vasculogenic potential of adult cardiac progenitor cells. PLoS One (2011) 0.84
Cell therapy in congestive heart failure. J Zhejiang Univ Sci B (2007) 0.83
Moving beyond surrogate endpoints in cell therapy trials for heart disease. Stem Cells Transl Med (2013) 0.82
Use of human embryonic stem cell derived-mesenchymal cells for cardiac repair. Biotechnol Bioeng (2011) 0.80
Lost in translation: what is limiting cardiomyoplasty and can tissue engineering help? Curr Stem Cell Res Ther (2009) 0.79
Blood vessel repair and regeneration in the ischaemic heart. Open Heart (2014) 0.79
Efficacy and safety of bone marrow cell transplantation for chronic ischemic heart disease: a meta-analysis. Med Sci Monit (2014) 0.79
Mesenchymal Stem Cells for Cardiac Regenerative Therapy: Optimization of Cell Differentiation Strategy. Stem Cells Int (2015) 0.79
Stem cell therapy for heart disease. J Gen Intern Med (2013) 0.78
Transmyocardial revascularization devices: technology update. Med Devices (Auckl) (2014) 0.78
Immunotolerant Properties of Mesenchymal Stem Cells: Updated Review. Stem Cells Int (2015) 0.78
Surgical treatment for congestive heart failure with autologous adult stem cell transplantation. J Thorac Cardiovasc Surg (2006) 0.77
[Surgical intramyocardial stem cell therapy for chronic ischemic heart failure]. Herz (2010) 0.77
Stem cell therapy for cardiovascular disease: the demise of alchemy and rise of pharmacology. Br J Pharmacol (2013) 0.76
The role of large animal studies in cardiac regenerative therapy concise review of translational stem cell research. Korean Circ J (2013) 0.76
Periprocedural adverse events in cell therapy trials in myocardial infarction and cardiomyopathy: a systematic review. Clin Res Cardiol (2012) 0.75
Stem cell transplantation for ischemic cardiomyopathy: hope or hype? J Thorac Cardiovasc Surg (2005) 0.75
Heart Failure: Diagnosis, Management and Utilization. J Clin Med (2016) 0.75
Use of autologous adult stem cell for treatment of congestive heart failure. J Thorac Cardiovasc Surg (2006) 0.75
An imperfect syllogism: granulocyte colony-stimulating factor mobilization and cardiac regeneration. J Am Coll Cardiol (2008) 0.75
Baylor's contribution to thoracic surgery and cardiac stem cell therapy for heart failure. Proc (Bayl Univ Med Cent) (2008) 0.75
Advances in stem cell therapy for cardiovascular disease (Review). Int J Mol Med (2016) 0.75
Cell Therapies in Cardiomyopathy: Current Status of Clinical Trials. Anal Cell Pathol (Amst) (2017) 0.75
Patient-specific computational modeling and magnetic nanoconstructs: tools for maximizing the efficacy of stem cell-based therapies. Methodist Debakey Cardiovasc J (2013) 0.75
A perspective on the surgical management of congestive heart failure. World J Surg (2008) 0.75
Left ventricular ejection fraction as therapeutic target: is it the ideal marker? Heart Fail Rev (2017) 0.75
Multipotent menstrual blood stromal stem cells: isolation, characterization, and differentiation. Cell Transplant (2008) 1.80
Modafinil for the treatment of cocaine dependence. Drug Alcohol Depend (2009) 1.77
Mechanical circulatory support device database of the International Society for Heart and Lung Transplantation: third annual report--2005. J Heart Lung Transplant (2005) 1.75
A micro-ribonucleic acid signature associated with recovery from assist device support in 2 groups of patients with severe heart failure. J Am Coll Cardiol (2011) 1.71
Mechanical Circulatory Support Device Database of the International Society for Heart and Lung Transplantation: second annual report--2004. J Heart Lung Transplant (2004) 1.40
Stem cell therapy with retrograde coronary perfusion in acute myocardial infarction. A new technique. Arq Bras Cardiol (2004) 1.38
Ventricular arrhythmias during left ventricular assist device support. Am J Cardiol (2007) 1.02
Long-term outcome of lung and heart-lung transplantation for idiopathic pulmonary arterial hypertension. Ann Thorac Surg (2008) 0.95
NMR structure of the human prion protein with the pathological Q212P mutation reveals unique structural features. PLoS One (2010) 0.92
Endoscopic radial artery harvesting is better than the open technique. Ann Thorac Surg (2004) 0.91
Prion protein and copper cooperatively protect neurons by modulating NMDA receptor through S-nitrosylation. Antioxid Redox Signal (2015) 0.90
Compact conformations of α-synuclein induced by alcohols and copper. Proteins (2011) 0.89
Posttraumatic stress disorder caused by hallucinations and delusions experienced in delirium. Psychosomatics (2007) 0.89
Effects of the pathological Q212P mutation on human prion protein non-octarepeat copper-binding site. Biochemistry (2012) 0.88
Structural insights into alternate aggregated prion protein forms. J Mol Biol (2009) 0.87
Successful diagnosis of penetrating cardiac injury using surgeon-performed sonography. Ann Thorac Surg (2003) 0.86
Towards the development of a pediatric ventricular assist device. Cell Transplant (2006) 0.86
Surgical management of esophageal carcinoma. Proc (Bayl Univ Med Cent) (2003) 0.86
Clinical benefits of leukocyte filtration during valve surgery. Am J Surg (2003) 0.81
Prion protein accumulation in lipid rafts of mouse aging brain. PLoS One (2013) 0.81
Modulation of alpha-synuclein aggregation by dopamine analogs. PLoS One (2010) 0.81
Longitudinal study of cryptococcosis in adult solid-organ transplant recipients. Transpl Int (2003) 0.79
Effect of the TNF-alpha-promoter polymorphism on cardiac allograft rejection. J Heart Lung Transplant (2004) 0.79
Which patients first? Planning the first clinical trial of xenotransplantation: a case for cardiac bridging. Xenotransplantation (2005) 0.78
Successful cidofovir treatment in an adult heart transplant recipient with severe adenovirus pneumonia. J Heart Lung Transplant (2008) 0.78
The role of Bax and caspase-3 in doppel-induced apoptosis of cerebellar granule cells. Prion (2012) 0.78
De novo prions. F1000 Biol Rep (2010) 0.78
Prolonged use of right ventricular assist device for refractory graft failure following orthotopic heart transplantation. J Thorac Cardiovasc Surg (2009) 0.76
Statement regarding the pre and post market assessment of durable, implantable ventricular assist devices in the United States. Circ Heart Fail (2012) 0.76
Left ventricular assist device. N Engl J Med (2002) 0.75
Use of general anesthetic only vs general anesthetic combined with paravertebral block for perioperative pain management after first rib resection. Proc (Bayl Univ Med Cent) (2002) 0.75
Direct myocardial implantation of human fetal stem cells in heart failure patients: long-term results. Heart Surg Forum (2010) 0.75
Patient selection and technical considerations for off-pump coronary surgery. Proc (Bayl Univ Med Cent) (2003) 0.75
Avoidance of lower-limb amputation by surgical implantation of autologous stem cells. Proc (Bayl Univ Med Cent) (2013) 0.75
How Should Remote Clinical Monitoring Be Used to Treat Alcohol Use Disorders?: Initial Findings From an Expert Round Table Discussion. J Addict Med (2017) 0.75
Permanent Continuous Flow Left Ventricular Assist Devices Use After Acute Stabilization for Cardiogenic Shock in Acute Myocardial Infarction. ASAIO J (2016) 0.75
Epicardial atrial defibrillation: successful treatment of postoperative atrial fibrillation. Ann Thorac Surg (2004) 0.75
Serial dobutamine stress echocardiography with Doppler assessment of the left internal thoracic artery graft after minimally invasive bypass for a patient with an orthotopic heart transplant. J Heart Lung Transplant (2004) 0.75
Statement regarding the pre and post market assessment of durable, implantable ventricular assist devices in the United States: executive summary. Circ Heart Fail (2012) 0.75
Statement regarding the pre and post market assessment of durable, implantable ventricular assist devices in the United States. J Heart Lung Transplant (2012) 0.75
Statement regarding the pre and post market assessment of durable, implantable ventricular assist devices in the United States: executive summary. Ann Thorac Surg (2012) 0.75
Statement regarding the pre and post market assessment of durable, implantable ventricular assist devices in the United States. Ann Thorac Surg (2012) 0.75
Percutaneous infusion system for in situ thrombolysis in the abdominal aorta and iliac arteries. J Endovasc Ther (2002) 0.75
Terbutaline for chronotropic support in heart transplantation. Ann Pharmacother (2004) 0.75